Skip to main content
NewslettersWatchlist

Edwards Lifesciences Corp(EW-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low69.96
Day High71.00
Open:70.31
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion of Market Capitalization - Hagens Berman
TheNewswire.com
EW CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) and Lead Plaintiff Deadline on December 13, 2024
TheNewswire.com
EDWARDS LIFESCIENCES DEADLINE FOR LEADERSHIP is December 13, 2024 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
Stock Target Advisor
Edwards Lifesciences Corp Q3 Earnings Beat Expectations with 9% Sales Growth
TheNewswire.com
EW DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before December 13, 2024
TheNewswire.com
EDWARDS LIFESCIENCES DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on December 13, 2024
TheNewswire.com
Edwards Lifesciences Deadline to Lead in Securities Fraud Lawsuit is December 13, 2024 - Contact Kaplan Fox & Kilsheimer LLP
TheNewswire.com
Deadline to Lead in Securities Fraud Lawsuit Against Edwards Lifesciences Corp. (EW) is December 13, 2024 - Contact Kaplan Fox & Kilsheimer LLP
TheNewswire.com
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Edwards Lifesciences Corp. (EW) - Deadline is December 13, 2024
Barchart
Stocks Slightly Higher Before FOMC Decision
Barchart
Stock Index Futures Tread Water With Fed Rate Decision in Focus
Motley Fool
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
Barchart
Stocks Finish Lower Ahead of Friday’s Comments from Fed Chair Powell
Barchart
Stocks Turn Cautious on Speculation Powell Will Downplay Aggressive Fed Easing
Barchart
Stocks Push Higher on Favorable Corporate News
Barchart
Stocks Set to Open Higher as Investors Await U.S. Jobs Data and Big Tech Earnings, Fed Meeting on Tap
Barchart
S&P Futures Climb as Key U.S. Inflation Data Looms
Barchart
Stocks Continue Lower on Economic Concerns and Negative Earnings Surprises
Barchart
Stocks Muted Before the Open as Investors Await Key U.S. GDP Data and Earnings Reports
Barchart
Stocks Pressured from Higher Bond Yields
Barchart
S&P Futures Tick Lower Ahead of FOMC Meeting Minutes, Nvidia Earnings in Focus
Barchart
S&P Futures Tick Lower as Key U.S. Jobs Report Looms

Profile

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.